' A brief mystery which sets the stage for the accompanying mini-review, seeking to integrate basic laboratory and clinical sciences and diverse expressions of disease, while highlighting the role of the generalist (that is, the integrator).
account for the progressive nature of his failure? Was it true that we are born with a fixed number of terminally differentiated cardiac myocytes -parenchyma so specialized as to be a one-trick dog? In the fetal heart, myocytes divide. The fetal phenotype was needed here. Could this puzzle not be unlocked or would this prove deleterious? This reminded her of Mr. R., a 33-year-old newspaper reporter who presented to her clinic with exertional dyspnea and near-syncope. On examination, no evidence of structural heart disease or pulmonary hypertension was found. ECG showed left bundle branch block; chest X-ray, enlargement of the cardiac silhouette and mediastinum. A localized thickening of the interventricular septum of uncertain etiology, with disordered wall motion and pericardial effusion, was seen on echocardiography. Because of his widened mediastinum and effusion, a malignancy was suspected. Mr. R. died suddenly days later. At autopsy, rhabdomyosarcoma with metastatic spread to thoracic lymph nodes was found. Nicole noted that this implicated both striated muscle and embryonic connective tissue cells. Had myocytes stimulated sarcomatous growth or vice versa? Relative to other organs, malignancy was rare in the heart. Did this relate to the inability of adult myocytes to divide? She longed to discuss these issues with her Professor. In the meantime, she would ponder them while basking in the sun. Perhaps the respite and a good novel would clear her thoughts.
Answer
In explanted human hearts, obtained from patients with advanced cardiac failure associated with ischemic heart disease and previous MI, scattered myocyte loss with foci of replacement fibrosis (microscopic scarring), together with interstitial fibrosis, is the major cause of adverse remodeling in the failing myocardium of ischemic origin.
The scar of MI accounts for 30% of total fibrous tissue while 70% is related to replacement and interstitial fibrosis that appear remote to the MI and involve the right and left ventricles.
Short-term biochemical studies previously suggested that myocytes were unable to proliferate (or divide) and the 20 million or so myocytes present at birth were all that was available. Recent morphologic evidence, obtained in hearts with long-standing hypertrophy of diverse cause, indicates that myocyte proliferation does occur. Experimental studies would suggest that gene therapy may unlock the puzzle and promote myocyte division. Whether such an approach would pose the potential for malignant growth is presently unknown.
